Insight Molecular Diagnostics (IMDX) Tax Provisions (2020 - 2025)
Insight Molecular Diagnostics (IMDX) posted Tax Provisions of -$97000.0 for Q4 2021, up 94.59% sequentially from -$1.8 million in Q2 2021, and down 161.01% YoY from $159000.0 in Q4 2020.
Insight Molecular Diagnostics (IMDX) Tax Provisions (2020 - 2025) Analysis & Trends
Insight Molecular Diagnostics has reported Tax Provisions for 2 years, with the latest figure at -$97000.0 in Q4 2021.
- Quarterly Tax Provisions fell 161.01% year-over-year to -$97000.0 in Q4 2021, while the trailing twelve-month figure through Sep 2024 was -$97000.0 (changed N/A YoY) and the FY2022 annual result came in at -$1.2 million, up 87.04% from the prior year.
- Tax Provisions grew to -$97000.0 in Q4 2021 per IMDX's latest filing, from -$1.8 million in the prior quarter.
- Over five years, Tax Provisions peaked at $1.1 million in Q1 2020 and troughed at -$7.6 million in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 167.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 208.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -300,000.00 |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 69.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 60.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 78.81 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 53.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 56.50 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 87.30 Mn |
| 10 | Insight Molecular Diagnostics | 158.03 Mn | 139.50 Mn | 157,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.55 Mn |
| Dec 31, 2024 | -12.74 Mn |
| Dec 31, 2021 | -97,000.00 |
| Jun 30, 2021 | -1.79 Mn |
| Mar 31, 2021 | -7.56 Mn |
| Dec 31, 2020 | 159,000.00 |
| Jun 30, 2020 | -2.19 Mn |
| Mar 31, 2020 | 1.10 Mn |